Glaucoma suspect: Diagnosis and management

Asia-Pacific Journal of Ophthalmology

Volumn 5, Issue 1, 2016, Pages 32-37

  Chang, Robert T ^a   Singh, Kuldev ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Diagnosis; Glaucoma suspect; Review; Therapy

Indexed keywords

DISEASE MANAGEMENT; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC NERVE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VISION DISORDERS; VISUAL FIELD;

DISEASE MANAGEMENT; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC NERVE; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 84988896087     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0000000000000173     Document Type: Review

References (63)

1. Malik R, Swanson WH, Garway-Heath DF. "Structure-function relationship" in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol. 2012;40:369-380.
2. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081-2090.
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
4. Parrish RK 2nd. Reframing the US Preventive Services Task Force recommendationson screening for glaucoma. Am J Ophthalmol. 2014;158: 860-862.
5. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994; 112:69-73.
6. Friedman DS, Wilson MR, Liebmann JM, et al. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol. 2004;138(Suppl 3):S19-S31.
7. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53(Suppl 1):S3-S10.
8. Lin PW, Friedman M, Lin HC, et al. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011;20: 553-558.
9. Nemesure B, Honkanen R, Hennis A, et al. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007;114:1810-1815.
10. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
11. European Glaucoma Prevention Study (EGPS) Group; Miglior S, Pfeiffer N, et al. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114:3-9.
12. Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group; Gordon MO, et al. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007;114:10-19.
13. Greenfield DS. Glaucomatous versus nonglaucomatous optic disc cupping: clinical differentiation. Semin Ophthalmol. 1999;14:95-108.
14. Piette SD, Sergott RC. Pathological optic-disc cupping. Curr Opin Ophthalmol. 2006;17:1-6.
15. Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999;106:2010-2015.
16. Leung CK, Yu M, Weinreb RN, et al. Retinal nervefiber layerimaging with spectral-domain optical coherence tomography: interpreting the RNFL maps in healthy myopic eyes. Invest Ophthalmol Vis Sci. 2012;53: 7194-7200.
17. Seider MI, Lee RY, Wang D, et al. Optic disk size variability between African, Asian, white, Hispanic, and Filipino Americans using Heidelberg retinal tomography. J Glaucoma. 2009;18:595-600.
18. Leske MC, Wu SY, Hennis A, et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115:85-93.
19. Drance SM, Begg IS. Sector haemorrhage-a probable acute ischaemic disc change in chronic simple glaucoma. Can J Ophthalmol. 1970;5: 137-141.
20. Suh MH, Park KH. Pathogenesis and clinical implications of optic disk hemorrhage in glaucoma. Surv Ophthalmol. 2014;59:19-29.
21. Primary open angle glaucoma suspect preferred practice pattern 2010. Available at: http://www.aao.org/preferred-practice-pattern/primary-openangle-glaucoma-suspect-ppp-october-20. Accessed September 19, 2015.
22. NICE Glaucoma: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. 2009. Available at: https://www.nice. org.uk/guidance/cg85. Accessed September 19, 2015.
23. Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44 (Suppl 1):S7-S93.
24. Okafor KC, Brandt JD. Measuring intraocular pressure. Curr Opin Ophthalmol. 2015;26:103-109.
25. Leidl MC, Choi CJ, Syed ZA, et al. Intraocular pressure fluctuation and glaucoma progression: what do we know? Br J Ophthalmol. 2014;98: 1315-1319.
26. Sit AJ. Intraocular pressure variations: causes and clinical significance. Can J Ophthalmol. 2014;49:484-488.
27. Mansouri K, Weinreb RN. Ambulatory 24-h intraocular pressure monitoring in the management of glaucoma. Curr Opin Ophthalmol. 2015;26:214-220.
28. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
29. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100:135-146.
30. Lin SC, Singh K, Jampel HD, et al. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology. 2007;114:1937-1949.
31. Kostanyan T, Wollstein G, Schuman JS. New developments in optical coherence tomography. Curr Opin Ophthalmol. 2015;26:110-115.
32. Nouri-Mahdavi K. Selecting visual field tests and assessing visual field deterioration in glaucoma. Can J Ophthalmol. 2014;49:497-505.
33. Chauhan BC, Garway-Heath DF, Goñi FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569-573.
34. Keltner JL, Johnson CA, Anderson DR, et al. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology. 2006;113:1603-1612.
35. Bussel II, Wollstein G, Schuman JS. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br J Ophthalmol. 2014; 98(Suppl 2):ii15-ii19.
36. Grewal DS, Tanna AP. Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography. Curr Opin Ophthalmol. 2013;24:150-161.
37. Kuang TM, Zhang C, Zangwill LM, et al. Estimating lead time gained by optical coherence tomography in detecting glaucoma before development of visual field defects. Ophthalmology. 2015;122:2002-2009.
38. Wollstein G, Kagemann L, Bilonick RA, et al. Retinal nerve fibre layer and visual function loss in glaucoma: the tipping point. Br J Ophthalmol. 2012; 96:47-52.
39. Leung CK. Diagnosing glaucoma progression with optical coherence tomography. Curr Opin Ophthalmol. 2014;25:104-111.
40. Balendra SI, Normando EM, Bloom PA, et al. Advances in retinal ganglion cell imaging. Eye (Lond). 2015;29:1260-1269.
41. Mastropasqua R, Agnifili L, Mattei PA, et al. Advanced morphological and functional magnetic resonance techniques in glaucoma. Biomed Res Int. 2015;2015:160454.
42. Markowitz SN, Reyes SV. Microperimetry and clinical practice: an evidence-based review. Can J Ophthalmol. 2013;48:350-357.
43. Kulkarni SV, Coupland SG, Stitt DM, et al. Efficacy of SLO-Microperimetry and Humphrey for evaluating macular sensitivity changes in advanced glaucoma. Can J Ophthalmol. 2013;48: 406-412.
44. Strouthidis NG, Chandrasekharan G, Diamond JP, et al. Teleglaucoma: ready to go? Br J Ophthalmol. 2014;98:1605-1611.
45. Verma S, Arora S, Kassam F, et al. Northern Alberta remote teleglaucoma program: clinical outcomes and patient disposition. Can J Ophthalmol. 2014;49:135-140.
46. Boey PY, Mansberger SL. Ocular hypertension: an approach to assessment and management. Can J Ophthalmol. 2014;49:489-496.
47. Lee JW, Chan CW, Wong MO, et al. A randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary results. Clin Ophthalmol. 2014;8:1987-1992.
48. Wong MO, Lee JW, Choy BN, et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. 2015;60:36-50.
49. Waisbourd M, Katz LJ. Selective laser trabeculoplasty as a first-line therapy: a review. Can J Ophthalmol. 2014;49:519-522.
50. Tanna AP, Lin AB. Medical therapy for glaucoma: what to add after a prostaglandin analogs? Curr Opin Ophthalmol. 2015;26:116-120.
51. Tanna AP, Rademaker AW, Stewart WC, et al. Meta-analysisof the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs. Arch Ophthalmol. 2010;128:825-833.
52. Parrish RK, Palmberg P, Sheu WP, et al. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688-703.
53. Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically: the Travatan Dosing Aid Study. Ophthalmology. 2009;116:191-199.
54. Wang W, He M, Zhou M, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma: a systematic review and meta-analysis. PLoS One. 2013;8:e84270.
55. Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clin Ophthalmol. 2015;9:833-841.
56. Moubayed SP, Hamid M, Choremis J, et al. An unusual finding of corneal edema complicating selective laser trabeculoplasty. Can J Ophthalmol. 2009;44:337-338.
57. Dirani M, Crowston JG, Taylor PS, et al. Economic impact of primary open-angle glaucoma in Australia. Clin Experiment Ophthalmol. 2011;39:623-632.
58. Lai JS, Chua JK, Tham CC, et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol. 2004;32: 368-372.
59. Budenz DL, Gedde SJ. New options for combined cataract and glaucoma surgery. Curr Opin Ophthalmol. 2014;25:141-147.
60. Kung JS, Choi DY, Cheema AS, et al. Cataract surgery in the glaucoma patient. Middle East Afr J Ophthalmol. 2015;22:10-17.
61. Mansberger SL, Gordon MO, Jampel H, et al. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology. 2012;119:1826-1831.
62. Dada T, Rathi A, Angmo D, et al. Clinical outcomes of clear lens extraction in eyes with primary angle closure. J Cataract Refract Surg. 2015;41: 1470-1477.
63. Trikha S, Perera SA, Husain R, et al. The role of lens extraction in the current management of primary angle-closure glaucoma. Curr Opin Ophthalmol. 2015;26:128-134.